IFN-Is at the interface of Innate and Adapative Immunity
IFN-Is at the interface of Innate and Adapative Immunity
批准号:
7916939
负责人:
CHRISTIAN W SCHINDLER
金额:
$23.51万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-15 至 2010-03-31
关键词:
AccountingAntigen-Presenting CellsAntiviral AgentsAreaBindingBiochemicalBiologicalCell NucleusCellsComplexCytokine Inducible SH2-Containing ProteinDendritic CellsExhibitsFamilyFibroblastsGene ExpressionGene TargetingGenesGeneticHistocompatibility Antigens Class IIHumanIFNAR1 geneImmuneImmune responseImmunityInterferon Type IInterferon Type IIInterferon-alphaInterferon-betaInterferonsInvestigationKineticsKnockout MiceMHC Class II GenesMediatingModificationMusNuclear ImportPathogenesisPathway interactionsPhosphoric Monoester HydrolasesPlayPrincipal InvestigatorPropertyProteinsRecruitment ActivityRegulationRoleSignal PathwaySignal TransductionSystemic Lupus ErythematosusTissuesTyrosine PhosphorylationUbiquitinUp-RegulationVirusVirus Diseasescytokinein vitro activitymacrophagemanprogramsprotein inhibitors of activated STATreceptorresponsetranscription factortype I interferon receptorubiquitin-protein ligase
中文摘要
描述(由申请人提供):干扰素(ifn)最初因其有效的抗病毒活性而被发现,可分为两大类。其中,II型或免疫IFN(又名IFN- γ)已经赢得了很多名声,但I型IFN (IFN- is,如IFN- α, IFN- β等)代表了一个更大更复杂的家族。与此一致的是,病毒已经进化出许多策略来阻止IFN-I的活性。最近,IFN-Is也因其是由浆状样树突状细胞(pDCs)分泌的主要效应细胞因子而声名鹊起。“天然IFN-I生成细胞”)。然后这些IFN-Is调节先天免疫和适应性免疫的各个方面。还有有趣的新证据表明,IFN-Is和pDCs在系统性红斑狼疮(SLE)的发病机制中发挥重要作用。
英文摘要
DESCRIPTION (provided by applicant): Interferons (IFNs), first identified for their potent antiviral activity, can be divided into two major classes. Of these, type II or immune IFN (a.k.a. IFN-gamma) has earned much notoriety, but the type I IFNs (IFN-Is; e.g., IFN-alpha, IFN-beta, etc.) represent a much larger and complex family. Consistent with this, viruses have evolved numerous strategies to thwart IFN-I activity. More recently, IFN-Is have also achieved some celebrity with the recognition that they are the major effector cytokine secreted by plasmacvtoid dendritic cells (pDCs, a.k.a. "Natural IFN-I Producing Cells"). These IFN-Is then regulate aspects of both innate and adaptive immunity. There is also intriguing new evidence that IFN-Is and pDCs play an important role in the pathogenesis of Systemic Lupus Erythematosis (SLE).
Like other cytokines, IFN-Is induce their potent activity through the induction of new genes. Characterization of the ability of IFN-alpha to rapidly induce genes led to the identification of Stat1 and Stat2, the first two STAT transcription factors. These STATs are recruited to the type I IFN receptor (IFNAR) by unknown mechanisms, whereupon they become activated (by tyrosine phosphorylation), dimerize, translocate to the nucleus and activate genes. In contrast, IFN-gamma transduces its signals solely through Stat1, albeit with differing kinetics.
To determine the unique role Stat2 plays in the biological response to IFN-Is, Stat2 knockout mice were generated. These mice were highly susceptible to viral infection and partially unresponsive to IFN-Is. Unexpectedly, they exhibited tissue-specific differences in IFN-I stimulated Statl activation and a loss in the normal regulation of the Major Histocompatibility Complex class II (MHC-II). These observations highlight the important role type I IFNs play in regulating innate and adaptive immunity. To understand how IFN-Is mediate their many potent effects we propose to:
1. Determine how STATs are activated at the type I IFN receptor, including tissue specific differences.
2. Determine the unique role Stat2 exhibits in regulating MHC-II expression in macrophages
3. Explore the role SUMOylation may play in regulating the kinetics of IFN stimulated STATs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Genetic characterization of the murine type I Interferon locus
-
批准号:8780594
-
项目类别:
-
资助金额:$19.78万
-
财政年份:2013
-
负责人:CHRISTIAN W SCHINDLER
-
依托单位:
Genetic characterization of the murine type I Interferon locus
-
批准号:8623890
-
项目类别:
-
资助金额:$23.7万
-
财政年份:2013
-
负责人:CHRISTIAN W SCHINDLER
-
依托单位:
Probing the Innate Response to 3', 5'-cyclic Diguanylate (c-diGMP)
-
批准号:8274633
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2011
-
负责人:CHRISTIAN W SCHINDLER
-
依托单位:
Probing the Innate Response to 3', 5'-cyclic Diguanylate (c-diGMP)
-
批准号:8176709
-
项目类别:
-
资助金额:$24.01万
-
财政年份:2011
-
负责人:CHRISTIAN W SCHINDLER
-
依托单位:
Characterization of the Innate Immune Response to Crystalline Silica
-
批准号:7512740
-
项目类别:
-
资助金额:$23.62万
-
财政年份:2009
-
负责人:CHRISTIAN W SCHINDLER
-
依托单位:
Characterization of the Innate Immune Response to Crystalline Silica
-
批准号:7846828
-
项目类别:
-
资助金额:$19.76万
-
财政年份:2009
-
负责人:CHRISTIAN W SCHINDLER
-
依托单位:
IFN-Is at the interface of Innate and Adapative Immunity
-
批准号:7391145
-
项目类别:
-
资助金额:$30.42万
-
财政年份:2004
-
负责人:CHRISTIAN W SCHINDLER
-
依托单位:
FLUORESCENCE-ACTIVATED CELL SORTER: DIABETES
-
批准号:6973150
-
项目类别:
-
资助金额:$7.96万
-
财政年份:2004
-
负责人:CHRISTIAN W SCHINDLER
-
依托单位:
FLUORESCENCE-ACTIVATED CELL SORTER: STEM CELLS: ADULT HUMAN, ADULT MOUSE
-
批准号:6973147
-
项目类别:
-
资助金额:$7.96万
-
财政年份:2004
-
负责人:CHRISTIAN W SCHINDLER
-
依托单位:
FLUORESCENCE-ACTIVATED CELL SORTER: AIDS
-
批准号:6973148
-
项目类别:
-
资助金额:$0.99万
-
财政年份:2004
-
负责人:CHRISTIAN W SCHINDLER
-
依托单位:
FLUORESCENCE-ACTIVATED CELL SORTER: ASTHMA
-
批准号:6973151
-
项目类别:
-
资助金额:$7.96万
-
财政年份:2004
-
负责人:CHRISTIAN W SCHINDLER
-
依托单位:
IFN-Is at the interface of Innate and Adapative Immunity
-
批准号:7210593
-
项目类别:
-
资助金额:$31.01万
-
财政年份:2004
-
负责人:CHRISTIAN W SCHINDLER
-
依托单位:
IFN-Is at the interface of Innate and Adapative Immunity
-
批准号:8145027
-
项目类别:
-
资助金额:$14.49万
-
财政年份:2004
-
负责人:CHRISTIAN W SCHINDLER
-
依托单位:
IFN-Is at the interface of Innate and Adpative Immunity
-
批准号:6884818
-
项目类别:
-
资助金额:$32.7万
-
财政年份:2004
-
负责人:CHRISTIAN W SCHINDLER
-
依托单位:
IFN-Is at the interface of Innate and Adpative Immunity
-
批准号:7039141
-
项目类别:
-
资助金额:$31.93万
-
财政年份:2004
-
负责人:CHRISTIAN W SCHINDLER
-
依托单位:
IFN-Is at the interface of Innate and Adapative Immunity
-
批准号:6827954
-
项目类别:
-
资助金额:$32.7万
-
财政年份:2004
-
负责人:CHRISTIAN W SCHINDLER
-
依托单位:
Fluorescence-Activated Cell Sorter
-
批准号:6735220
-
项目类别:
-
资助金额:$32.84万
-
财政年份:2004
-
负责人:CHRISTIAN W SCHINDLER
-
依托单位:
FLUORESCENCE-ACTIVATED CELL SORTER: CANCER,
-
批准号:6973149
-
项目类别:
-
资助金额:$7.96万
-
财政年份:2004
-
负责人:CHRISTIAN W SCHINDLER
-
依托单位:
COLUMBIA UNIVERSITY ASTHMA AND ALLERGY CLINICAL RESEARCH
-
批准号:6895290
-
项目类别:
-
资助金额:$154.92万
-
财政年份:2001
-
负责人:CHRISTIAN W SCHINDLER
-
依托单位:
COLUMBIA UNIVERSITY ASTHMA AND ALLERGY CLINICAL RESEARCH
-
批准号:6751921
-
项目类别:
-
资助金额:$152.01万
-
财政年份:2001
-
负责人:CHRISTIAN W SCHINDLER
-
依托单位:
海外基金